Assessing Immune-Related Side Effects from Therapy
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- M.D. Anderson Cancer Center · Other
This trial is looking for people to share their experiences with side effects from a specific type of cancer treatment. Participants should have had recent treatment for arthritis or similar conditions and be able to talk about their experiences.
You may be able to join if
- I am 18 years old or older
- I speak English at a conversational level
- I can give informed consent
- I have been diagnosed with inflammatory arthritis or PMR after ICI therapy
You may not be able to join if
- I have a life-threatening or worsening cancer
- I have hearing problems that would prevent me from participating in verbal interviews
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityTo understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
Loading trial locations…